返回首页

HCK P08631

酪氨酸蛋白激酶 HCK (EC 2.7.10.2) (造血细胞激酶) (造血细胞激酶) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)

蛋白质信息 (UniProt)

酪氨酸蛋白激酶 HCK (EC 2.7.10.2) (造血细胞激酶) (造血细胞激酶) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)

P08631

功能描述

发现于造血细胞的非受体酪氨酸蛋白激酶,传递来自细胞表面受体的信号,并在先天免疫反应的调节中发挥重要作用,包括中性粒细胞、单核细胞、巨噬细胞和肥大细胞功能、吞噬作用、细胞存活和增殖、细胞粘附和迁移。作用于结合免疫球蛋白Fc区的受体下游,如FCGR1A和FCGR2A,以及CSF3R、PLAUR、IFNG、IL2、IL6和IL8的受体,以及整合素,如ITGB1和ITGB2。在吞噬过程中,介导分泌溶酶体的动员、脱颗粒和NADPH氧化酶的激活以引起呼吸爆发。在炎症分子的释放中发挥作用。促进肌动蛋白细胞骨架的重排和肌动蛋白聚合、足体和细胞突起的形成。抑制TP73介导的转录激活和TP73介导的细胞凋亡。响应免疫球蛋白γ Fc区受体的激活磷酸化CBL。磷酸化ADAM15、BCR、ELMO1、FCGR2A、GAB1、GAB2、RAPGEF1、STAT5B、TP73、VAV1和WAS。 {ECO:0000269|PubMed:10092522, ECO:0000269|PubMed:10779760, ECO:0000269|PubMed:10973280, ECO:0000269|PubMed:11741929, ECO:0000269|PubMed:11896602, ECO:0000269|PubMed:12411494, ECO:0000269|PubMed:15010462, ECO:0000269|PubMed:15952790, ECO:0000269|PubMed:15998323, ECO:0000269|PubMed:17310994, ECO:0000269|PubMed:17535448, ECO:0000269|PubMed:19114024, ECO:0000269|PubMed:19903482, ECO:0000269|PubMed:20452982, ECO:0000269|PubMed:21338576, ECO:0000269|PubMed:7535819, ECO:0000269|PubMed:8132624, ECO:0000269|PubMed:9406996, ECO:0000269|PubMed:9407116}.

组织特异性

Detected in monocytes and neutrophils (at protein level). Expressed predominantly in cells of the myeloid and B-lymphoid lineages. Highly expressed in granulocytes. Detected in tonsil.

亚细胞定位

[Isoform 1]: Lysosome. Membrane; Lipid-anchor. Cell projection, podosome membrane; Lipid-anchor. Cytoplasm, cytosol. Note=Associated with specialized secretory lysosomes called azurophil granules. At least half of this isoform is found in the cytoplasm, some of this fraction is myristoylated.; SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane

关键词

3D-structure Alternative initiation Alternative splicing ATP-binding Cell junction Cell membrane Cell projection Cytoplasm Cytoplasmic vesicle Cytoskeleton